Advertisement

Treatment of Cancer-related-Fatigue in Acute Hematological Malignancies: Results of a Feasibility Study of using Cognitive Behavioral Therapy

      Abstract

      Background

      Despite cancer related fatigue (CRF) being the most common, and debilitating symptom in patients with recently diagnosed acute hematological malignancies (HM), there are limited effective treatments for CRF in HM. The aim of this study was to determine the feasibility of cognitive behavioral therapy (CBT) for CRF in HM.

      Methods

      In this preliminary longitudinal prospective study, HM patients diagnosed a median of one month previously with moderate to severe fatigue were enrolled. Patients received CBT in seven weekly sessions for eight weeks. Change in Functional Assessment of Cancer Illness Therapy (FACIT) - Fatigue (primary), FACT-G, Pittsburg Sleep Quality Index (PSQI), Hospital Anxiety Depression Scale (HADS), M.D. Anderson Symptom Inventory - Acute Myeloid Leukemia (MDASI-AML/MDS), and Herth Hope Index (HHI) were analyzed.

      Results

      Twenty-seven of 36 (75 %) patients were evaluable. Adherence and satisfaction rates to the CBT intervention were 78.6% (95% CI 67.2%, 89.9%), and 92% (95% CI 76.7%, 98.3%) respectively. The median age 66, 64% female, the most common HM was AML (60%), median FACIT-F was 27. The mean (SD) improvement at end eight weeks for FACIT-F was 5.5(13.6), Cohen δ 0.4, P=0.046; and for PSQI total was 2.9 (3), Cohen δ -1, P=0.006. We also found significant improvement in HADS anxiety -2.7(4.5), P=0.049, MDASI Sleep -1.8(3.0), P=0.022, MDASI mean module symptom severity -0.7(1.6), P=0.006. However, no significant improvements were found in FACT-G, HHI, and HADS-depression scores.

      Conclusions

      The use of CBT was feasible with improvement of CRF, sleep quality, and anxiety scores in HM. Randomized controlled trials are justified.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Pain and Symptom Management
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. Meyers C, Albitar M, Estey E (2005) Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome, 104. doi:10.1002/cncr.21234

        • Alibhai SMH
        • Leach M
        • Kowgier ME
        • Tomlinson GA
        • Brandwein JM
        • Minden MD
        Fatigue in older adults with acute myeloid leukemia: predictors and associations with quality of life and functional status.
        Leukemia. 2007; 21: 845https://doi.org/10.1038/sj.leu.2404576
        • Musarezaie A
        • Khaledi F
        • Esfahani HN
        • Ghaleghasemi TM
        Factors affecting quality of life and fatigue in patients with leukemia under chemotherapy.
        J Educ Health Promo. 2014; 3: 64https://doi.org/10.4103/2277-9531.134778
        • Zhou Y
        • Zhu J
        • Gu Z
        • Yin X
        Efficacy of exercise interventions in patients with acute leukemia: a meta-analysis.
        PLoS One. 2016; 11e0159966https://doi.org/10.1371/journal.pone.0159966
        • Schumacher A
        • Wewers D
        • Heinecke A
        • et al.
        Fatigue as an important aspect of quality of life in patients with acute myeloid leukemia.
        Leuk Res. 2002; 26: 355-362https://doi.org/10.1016/s0145-2126(01)00145-x
        • Leak Bryant A
        • Lee Walton A
        • Shaw-Kokot J
        • Mayer DK
        • Reeve BB
        Patient-reported symptoms and quality of life in adults with acute leukemia: a systematic review.
        Oncol Nurs Forum. 2015; 42: E91-e101https://doi.org/10.1188/15.onf.e91-e101
        • Wang XS
        • Giralt SA
        • Mendoza TR
        • et al.
        Clinical factors associated with cancer-related fatigue in patients being treated for leukemia and non-Hodgkin's lymphoma.
        J Clin Oncol. 2002; 20: 1319-1328https://doi.org/10.1200/jco.2002.20.5.1319
        • Wang XS
        • Woodruff JF
        Cancer-related and treatment-related fatigue.
        Gynecol Oncol. 2015; 136: 446-452https://doi.org/10.1016/j.ygyno.2014.10.013
        • Curt GA
        • Breitbart W
        • Cella D
        • et al.
        Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition.
        Oncologist. 2000; 5: 353-360
        • Lacourt TE
        • Kavelaars A
        • Ohanian M
        • et al.
        Patient-reported fatigue prior to treatment is prognostic of survival in patients with acute myeloid leukemia.
        Oncotarget. 2018; 9: 31244-31252https://doi.org/10.18632/oncotarget.25787
        • Berger AM
        • Mooney K
        • Alvarez-Perez A
        • et al.
        Cancer-related fatigue, version 2.2015.
        J Natl Compr Canc Netw. 2015; 13: 1012-1039https://doi.org/10.6004/jnccn.2015.0122
        • Mustian KM
        • Alfano CM
        • Heckler C
        • et al.
        Comparison of pharmaceutical, psychological, and exercise treatments for cancer-related fatigue: a meta-analysis.
        JAMA Oncol. 2017; 3: 961-968https://doi.org/10.1001/jamaoncol.2016.6914
        • Dimeo F
        • Schmittel A
        • Fietz T
        • et al.
        Physical performance, depression, immune status and fatigue in patients with hematological malignancies after treatment.
        Annals Oncol. 2004; 15: 1237-1242https://doi.org/10.1093/annonc/mdh314
        • Respini D
        • Jacobsen PB
        • Thors C
        • et al.
        The prevalence and correlates of fatigue in older cancer patients.
        Crit Rev Oncol Hematol. 2003; 47: 273-279https://doi.org/10.1016/s1040-8428(02)00176-2
        • Bourke L
        • Smith D
        • Steed L
        Exercise for men with prostate cancer: a systematic review and meta-analysis.
        Eur Urol. 2016; 69: 693-703https://doi.org/10.1016/j.eururo.2015.10.047
        • Yeh C-T
        • Wang L-S
        Potential pathophysiological mechanism of cancer-related fatigue and current management.
        Formosan J Surg. 2014; 47: 173-182https://doi.org/10.1016/j.fjs.2014.09.001
        • Saligan LN
        • Olson K
        • Filler K
        • et al.
        The biology of cancer-related fatigue: a review of the literature.
        Support Care Cancer. 2015; 23: 2461-2478https://doi.org/10.1007/s00520-015-2763-0
        • Poort H
        • Müller F
        • Bleijenberg G
        • et al.
        Condition or cognition? Mechanism of change in fatigue in a randomized controlled trial of graded exercise therapy or cognitive behavior therapy for severe fatigue in patients with advanced cancer.
        J Consult Clin Psychol. 2021; 89: 731-741https://doi.org/10.1037/ccp0000670
        • Jarden M
        • Adamsen L
        • Kjeldsen L
        • et al.
        The emerging role of exercise and health counseling in patients with acute leukemia undergoing chemotherapy during outpatient management.
        Leuk Res. 2013; 37: 155-161https://doi.org/10.1016/j.leukres.2012.09.001
        • Chang PH
        • Lai YH
        • Shun SC
        • et al.
        Effects of a walking intervention on fatigue-related experiences of hospitalized acute myelogenous leukemia patients undergoing chemotherapy: a randomized controlled trial.
        J Pain Symptom Manage. 2008; 35: 524-534https://doi.org/10.1016/j.jpainsymman.2007.06.013
        • Stepanski EJ
        • Walker MS
        • Schwartzberg LS
        • Blakely LJ
        • Ong JC
        • Houts AC
        The relation of trouble sleeping, depressed mood, pain, and fatigue in patients with cancer.
        J Clin Sleep Med. 2009; 5: 132-136
        • Goedendorp MM
        • Gielissen MF
        • Verhagen CA
        • Bleijenberg G
        Psychosocial interventions for reducing fatigue during cancer treatment in adults.
        Cochrane Database Syst Rev. 2009; Cd006953https://doi.org/10.1002/14651858.CD006953.pub2
        • Jacobsen PB
        • Donovan KA
        • Vadaparampil ST
        • Small BJ
        Systematic review and meta-analysis of psychological and activity-based interventions for cancer-related fatigue.
        Health Psychol. 2007; 26: 660-667https://doi.org/10.1037/0278-6133.26.6.660
        • Müller F
        • Wijayanto F
        • Abrahams H
        • et al.
        Potential mechanisms of the fatigue-reducing effect of cognitive-behavioral therapy in cancer survivors: Three randomized controlled trials.
        Psychooncology. 2021; 30: 1476-1484https://doi.org/10.1002/pon.5710
        • Goedendorp MM
        • Gielissen MF
        • Verhagen CA
        • Bleijenberg G
        Psychosocial interventions for reducing fatigue during cancer treatment in adults.
        Cochrane Database Syst Rev. 2009; 2009Cd006953https://doi.org/10.1002/14651858.CD006953.pub2
        • David N
        • Schlenker P
        • Prudlo U
        • Larbig W
        Internet-based program for coping with cancer: a randomized controlled trial with hematologic cancer patients.
        Psychooncology. 2013; 22: 1064-1072https://doi.org/10.1002/pon.3104
        • Betiar A
        • Khorrami N
        • Makvandi B
        Effectiveness of cognitive-behavioral therapy and mental imagery exercises on health-related quality of life among patients with leukemia and lymphoma.
        J Client-Centered Nurs Care. 2022; 8https://doi.org/10.32598/JCCNC.8.1.412.1
        • Jim HSL
        • Hyland KA
        • Nelson AM
        • et al.
        Internet-assisted cognitive behavioral intervention for targeted therapy-related fatigue in chronic myeloid leukemia: Results from a pilot randomized trial.
        Cancer. 2020; 126: 174-180https://doi.org/10.1002/cncr.32521
        • Prinsen H
        • Bleijenberg G
        • Heijmen L
        • et al.
        The role of physical activity and physical fitness in postcancer fatigue: a randomized controlled trial.
        Support Care Cancer. 2013; 21: 2279-2288https://doi.org/10.1007/s00520-013-1784-9
        • Gielissen MF
        • Verhagen S
        • Witjes F
        • Bleijenberg G
        Effects of cognitive behavior therapy in severely fatigued disease-free cancer patients compared with patients waiting for cognitive behavior therapy: a randomized controlled trial.
        J Clin Oncol. 2006; 24: 4882-4887https://doi.org/10.1200/jco.2006.06.8270
        • Abrahams HJG
        • Gielissen MFM
        • Donders RRT
        • et al.
        The efficacy of Internet-based cognitive behavioral therapy for severely fatigued survivors of breast cancer compared with care as usual: a randomized controlled trial.
        Cancer. 2017; 123: 3825-3834https://doi.org/10.1002/cncr.30815
        • Gielissen MF
        • Verhagen CA
        • Bleijenberg G
        Cognitive behaviour therapy for fatigued cancer survivors: long-term follow-up.
        Br J Cancer. 2007; 97: 612-618https://doi.org/10.1038/sj.bjc.6603899
        • D C
        Manual of the Functional Assessment of Chronic illness Therapy (FACIT) Measurement System. Center on Outcomes, Research and Education (CORE).
        Northwestern Healthcare and Northwestern University, Evanston, IL1997
        • Cella DF
        • Tulsky DS
        • Gray G
        • et al.
        The functional assessment of cancer therapy scale: development and validation of the general measure.
        J Clin Oncol. 1993; 11: 570-579https://doi.org/10.1200/jco.1993.11.3.570
        • Yennurajalingam S
        • Frisbee-Hume S
        • Delgado-Guay MO
        • et al.
        Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer.
        J Clin Oncol. 2013; 31: 3076-3082https://doi.org/10.1200/JCO.2012.44.4661
        • Bruera E
        • Driver L
        • Barnes EA
        • et al.
        Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report.
        J Clin Oncol. 2003; 21: 4439-4443https://doi.org/10.1200/JCO.2003.06.156
        • Bruera E
        • El Osta B
        • Valero V
        • et al.
        Donepezil for cancer fatigue: a double-blind, randomized, placebo-controlled trial.
        J Clin Oncol. 2007; 25: 3475-3481https://doi.org/10.1200/jco.2007.10.9231
        • Bruera E
        • Valero V
        • Driver L
        • et al.
        Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial.
        J Clin Oncol. 2006; 24: 2073-2078https://doi.org/10.1200/JCO.2005.02.8506
        • Minton O
        • Richardson A
        • Sharpe M
        • Hotopf M
        • Stone P
        A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue.
        J Natl Cancer Inst. 2008; 100: 1155-1166https://doi.org/10.1093/jnci/djn250
        • Yennu S
        • Basen-Engquist K
        • Reed VK
        • et al.
        Multimodal therapy for cancer related fatigue in patients with prostate cancer receiving radiotherapy and androgen deprivation therapy.
        Am Soc Clin Oncol. 2017; 35: 10114https://doi.org/10.1200/jco.2017.35.15_suppl.10114
        • Overcash J
        • Extermann M
        • Parr J
        • Perry J
        • Balducci L
        Validity and reliability of the FACT-G scale for use in the older person with cancer.
        Am J Clin Oncol. 2001; 24: 591-596https://doi.org/10.1097/00000421-200112000-00013
        • Johnston M
        • Pollard B
        • Hennessey P
        Construct validation of the hospital anxiety and depression scale with clinical populations.
        J Psychosom Res. 2000; 48: 579-584https://doi.org/10.1016/s0022-3999(00)00102-1
        • Bysse D
        • Reynolds III C
        • Monk T
        The Pittsburgh Sleep Quality Index (PSQI): a new instrument for psychiatric research and practice.
        Psychiatry Res. 1989; 28: 193-213
        • Ault PS
        • Kantarjian HM
        • Garcia-Manero G
        • et al.
        Symptom burden in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
        Am Soc Hematol. 2013;
        • Redlich-Amirav D
        • Ansell LJ
        • Harrison M
        • Norrena KL
        • Armijo-Olivo S
        Psychometric properties of hope scales: a systematic review.
        Int J Clin Pract. 2018; : e13213https://doi.org/10.1111/ijcp.13213
        • Reddy S
        • Bruera E
        • Pace E
        • Zhang K
        • Reyes-Gibby C
        Clinically important improvement in the intensity of fatigue in patients with advanced cancer.
        J Palliat Med. 2007; 10: 1068-1075https://doi.org/10.1089/jpm.2007.0007
        • Cella D
        • Eton DT
        • Lai JS
        • Peterman AH
        • Merkel DE
        Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales.
        J Pain Symptom Manage. 2002; 24: 547-561https://doi.org/10.1016/s0885-3924(02)00529-8
        • Alibhai SMH
        • Leach M
        • Kowgier ME
        • Tomlinson GA
        • Brandwein JM
        • Minden MD
        Fatigue in older adults with acute myeloid leukemia: predictors and associations with quality of life and functional status.
        Leukemia. 2007; 21: 845-848https://doi.org/10.1038/sj.leu.2404576
        • Blumenstein KG
        • Brose A
        • Kemp C
        • et al.
        Effectiveness of cognitive behavioral therapy in improving functional health in cancer survivors: a systematic review and meta-analysis.
        Crit Rev Oncol Hematol. 2022; 175103709https://doi.org/10.1016/j.critrevonc.2022.103709
        • Bower JE
        The role of neuro-immune interactions in cancer-related fatigue: biobehavioral risk factors and mechanisms.
        Cancer. 2019; 125: 353-364https://doi.org/10.1002/cncr.31790
        • Blackwood J
        • Rybicki K
        Physical function measurement in older long-term cancer survivors.
        J Frailty Sarcopenia Fall. 2021; 6: 139-146https://doi.org/10.22540/jfsf-06-139
        • Grusdat NP
        • Stäuber A
        • Tolkmitt M
        • et al.
        Routine cancer treatments and their impact on physical function, symptoms of cancer-related fatigue, anxiety, and depression.
        Supp Care Cancer. 2022; 30: 3733-3744https://doi.org/10.1007/s00520-021-06787-5
        • Martin T
        • Twomey R
        • Medysky ME
        • Temesi J
        • Culos-Reed SN
        • Millet GY
        The relationship between fatigue and actigraphy-derived sleep and rest-activity patterns in cancer survivors.
        Curr Oncol (Toronto, Ont). 2021; 28: 1170-1182https://doi.org/10.3390/curroncol28020113
        • Yennurajalingam S
        • Carmack C
        • Balachandran D
        • et al.
        Sleep disturbance in patients with cancer: a feasibility study of multimodal therapy.
        BMJ Support Palliat Care. 2021; 11: 170https://doi.org/10.1136/bmjspcare-2019-001877